Hedvig Nordeng

Prof. Hedvig Nordeng

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2009 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
HNHedvig Nordeng
Hedvig Nordeng
EYEivind Ystrøm
Eivind Ystrøm
AEAdrienne Einarson
Adrienne Einarson

12 December 2013 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
DKDeborah A Kennedy
Deborah A Kennedy
Angela LupattelliAngela Lupattelli
Angela Lupattelli
GKGideon Koren
Gideon Koren
HNHedvig Nordeng
Hedvig Nordeng
The use of complementary and alternative medicines (CAM) is growing in the general population. Herbal medicines are used in all countries of the world and are included in the top CAM therapies used.

25 June 2014 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
JSJanne Smedberg
Janne Smedberg
Angela LupattelliAngela Lupattelli
Angela Lupattelli
AMAnn-Charlotte Mårdby
Ann-Charlotte Mårdby
HNHedvig Nordeng
Hedvig Nordeng
Some women continue smoking during pregnancy despite the extensive information available on the dangers smoking poses to their fetus. This study aimed to examine the prevalence and determinants of smoking before and during pregnancy and the extent of smoking during pregnancy from a European perspective in relation to maternal sociodemographic characteristics, health literacy, morbidity, and pregnancy-related factors.

28 February 2017 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
KHKristine Heitmann
Kristine Heitmann
HNHedvig Nordeng
Hedvig Nordeng
GHGro C. Havnen
Gro C. Havnen
ASAnja Solheimsnes
Anja Solheimsnes
LHLone Holst
Lone Holst
Though nausea and vomiting is very common during pregnancy, no studies have investigated the impact of this condition on the women’s daily lives in a Scandinavian population. The aim of this study was to describe the burden of nausea and vomiting during pregnancy (NVP) on global quality of life, daily life functioning and willingness to become pregnant again according to the severity of NVP symptoms. This study is a cross-sectional population-based study conducted in Norway. Pregnant women and mothers with children <1 year of age with current or prior NVP were eligible to participate. Data were collected through an anonymous on-line questionnaire accessible from November 10th, 2014 to January 31st, 2015. Severity of NVP was measured using the 24-h Pregnancy Unique Quantification of Emesis Scale (PUQE). Associations between severity of NVP, daily life functioning and willingness to become pregnant again were tested using chi-square tests. Associations with global quality of life measured in terms of the Quality of Life Scale (QOLS) were estimated using generalized linear models and reported as unstandardized regression coefficients (β) with 95% confidence intervals (CI). 712 women with NVP were included in the study. NVP was significantly associated with several characteristics, including daily life functioning, quality of life and willingness to become pregnant again. The negative impact was greater the more severe the symptoms were, although considerable adverse effects were also seen among women with mild and moderate NVP symptoms. Over one fourth of the women with severe NVP considered terminating the pregnancy due to NVP, and three in four considered not to get pregnant again. Severity of NVP remained significantly associated with reduced global quality of life when adjusting for maternal characteristics and illnesses with β (95% CI) = −10.9 (−16.9, −4.9) for severe versus mild NVP. NVP as measured by PUQE had a major impact on various aspects of the women’s lives, including global quality of life and willingness to become pregnant again.

1 August 2011 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
HNHedvig Nordeng
Hedvig Nordeng
KBKaren Bayne
Karen Bayne
GHGro Cecilie Havnen
Gro Cecilie Havnen
BPBerit Smestad Paulsen
Berit Smestad Paulsen

15 March 2016 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
DKD. A. Kennedy
D. A. Kennedy
Angela LupattelliAngela Lupattelli
Angela Lupattelli
GKGideon Koren
Gideon Koren
HNHedvig Nordeng
Hedvig Nordeng
The use of herbal medicines for health prevention and ailments is an increasing trend worldwide. Women in pregnancy are no exception; the reported prevalence of herbal medicine use in pregnancy ranges from 1 to 60 %. Despite a common perception of safety, herbal medicines may have potent pharmacological actions, and historically, have been used for this reason. A multinational, cross-sectional study on how women treat disease and pregnancy-related health ailments was conducted between October 2011 and February 2012 in Europe, North America, and Australia. This study’s primary aim was to evaluate and classify the herbal medicines used according to their safety in pregnancy and, secondly, to investigate risk factors associated with the use of contraindicated herbal medicines during pregnancy. In total, 29.3 % of the women (n = 2673) reported the use of herbal medicines in pregnancy; of which we were able to identify 126 specific herbal medicines used by 2379 women (89.0 %). Twenty seven out of 126 herbal medicines were classified as contraindicated in pregnancy, and were used by 476 women (20.0 %). Twenty-eight were classified as safe for use in pregnancy and used by the largest number of women (n = 1128, 47.4 %). The greatest number was classified as requiring caution in pregnancy; these sixty herbal medicines were used by 751 women (31.6 %). Maternal factors associated with the use of contraindicated herbal medicines in pregnancy were found to be working in the home, having a university education, not using folic acid, and consuming alcohol. Interestingly, the recommendation to take a contraindicated herbal medicine was three times more likely to be from a healthcare practitioner (HCP) than an informal source. Based on the current literature the majority of women in this study used an herbal medicine that was classified as safe for use in pregnancy. Women who reported taking a contraindicated herb were more likely to have been recommended it use by an HCP rather than informal source(s), indicating an urgent need for more education among HCPs. The paucity of human studies on herbal medicines safety in pregnancy stands in stark contrast to the widespread use of these products among pregnant women.